Sunitinib malate and Insomnia - a phase IV clinical study of FDA data

Summary:

Insomnia is reported as a side effect among people who take Sunitinib malate (sunitinib malate), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Afinitor, and have Paraganglion neoplasm malignant.

The phase IV clinical study analyzes which people have Insomnia when taking Sunitinib malate. It is created by eHealthMe based on reports of 9,155 people who have side effects when taking Sunitinib malate from the FDA, and is updated regularly.

What is Sunitinib malate?

Sunitinib malate has active ingredients of sunitinib malate. eHealthMe is studying from 9,160 Sunitinib malate users. Check the latest studies of Sunitinib malate.

What is Insomnia?

Insomnia (sleeplessness) is found to be associated with 3,115 drugs and 5,172 conditions by eHealthMe. Check the latest studies of Insomnia.

On Aug, 06, 2026

9,155 people reported to have side effects when taking Sunitinib malate.
Among them, 40 people (0.44%) have Insomnia.

Among these 40 people:

How long have people been on Sunitinib malate when they have Insomnia? *

What is the gender of people who have Insomnia when taking Sunitinib malate? *

female: 82.05 %
male: 17.95 %

What is the age of people who have Insomnia when taking Sunitinib malate? *

What are other drugs people take besides Sunitinib malate? *

What are other side effects people have besides Insomnia? *

Headache (pain in head): 28 people, 70.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 24 people, 60.00%
Metastases To Bone (cancer spreads to bone): 19 people, 47.50%
Metastases To Central Nervous System (cancer spreads to central nervous system): 18 people, 45.00%
Metastases To Liver (cancer spreads to liver): 18 people, 45.00%
Pain In Extremity: 6 people, 15.00%
Weakness: 6 people, 15.00%
Nausea (feeling of having an urge to vomit): 6 people, 15.00%
Fatigue (feeling of tiredness): 6 people, 15.00%
Pleural Effusion (water on the lungs): 6 people, 15.00%

What are the existing conditions these people have? *

Paraganglion Neoplasm Malignant (paraganglion cancerous tumour): 24 people, 60.00%
Phaeochromocytoma (vascular tumour of the adrenal gland): 17 people, 42.50%
Renal Cell Carcinoma (a kidney cancer): 5 people, 12.50%
Phaeochromocytoma Malignant (cancer of the adrenal gland): 5 people, 12.50%
Metastases To Bone (cancer spreads to bone): 4 people, 10.00%
Fever: 3 people, 7.50%
Headache (pain in head): 3 people, 7.50%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 5.00%
Gastrointestinal Stromal Tumor: 2 people, 5.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sunitinib malate and have Insomnia?

- Check whether Insomnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sunitinib malate:

Sunitinib malate (9,160 reports)

Insomnia treatments and more:

Insomnia (438,081 reports)

Browse all side effects of Sunitinib malate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Insomnia:

Insomnia (3,115 drugs)

Browse all the conditions that are associated with Insomnia:

Insomnia (5,172 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sunitinib malate (the active ingredients of Sunitinib malate) and Sunitinib malate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.